References
Key articles
Rajput AH, Offord KP, Beard CM, et al. Essential tremor in Rochester, Minnesota: a 45-year study. J Neurol Neurosurg Psychiatry. 1984 May;47(5):466-70.Full text Abstract
Louis ED. Etiology of essential tremor: should we be searching for environmental causes? Mov Disord. 2001 Sep;16(5):822-9. Abstract
Benito-Leon J, Louis ED. Clinical update: diagnosis and treatment of essential tremor. Lancet. 2007 Apr 7;369(9568):1152-4. Abstract
Zesiewicz TA, Elble RJ, Louis ED, et al. Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology. 2011 Nov 8;77(19):1752-5.Full text Abstract
Sydow O, Thobois S, Alesch F, et al. Multicentre European study of thalamic stimulation in essential tremor: a six year follow up. J Neurol Neurosurg Psychiatry. 2003 Oct;74(10):1387-91.Full text Abstract
Elias WJ, Lipsman N, Ondo WG, et al. A randomized trial of focused ultrasound thalamotomy for essential tremor. N Engl J Med. 2016 Aug 25;375(8):730-9.Full text Abstract
Reference articles
1. Brennan KC, Jurewicz EC, Ford B, et al. Is essential tremor predominantly a kinetic or a postural tremor? A clinical and electrophysiological study. Mov Disord. 2002 Mar;17(2):313-6. Abstract
2. Elble RJ. Essential tremor frequency decreases with time. Neurology. 2000 Nov 28;55(10):1547-51. Abstract
3. Zeuner KE, Deuschl G. An update on tremors. Curr Opin Neurol. 2012 Aug;25(4):475-82. Abstract
4. Bhatia KP, Bain P, Bajaj N, et al. Consensus statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018 Jan;33(1):75-87.Full text Abstract
5. Deuschl G, Bain P, Brin M; Ad Hoc Scientific Committee. Consensus statement of the Movement Disorder Society on tremor. Mov Disord. 1998;13(suppl 3):2-23. Abstract
6. Louis ED. Clinical practice. Essential tremor. N Engl J Med. 2001 Sep 20;345(12):887-91. Abstract
7. Rydz D, Lin CY, Xie T, et al. Pathological findings of anti-Yo cerebellar degeneration with Holmes tremor. J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):121-2.Full text Abstract
8. Gasparini M, Bonifati V, Fabrizio E, et al. Frontal lobe dysfunction in essential tremor: a preliminary study. J Neurol. 2001 May;248(5):399-402. Abstract
9. Lacritz LH, Dewey R, Jr., Giller C, et al. Cognitive functioning in individuals with "benign" essential tremor. J Int Neuropsychol Soc. 2002 Jan;8(1):125-9. Abstract
10. Lombardi WJ, Woolston DJ, Roberts JW, et al. Cognitive deficits in patients with essential tremor. Neurology. 2001 Sep 11;57(5):785-90. Abstract
11. Chatterjee A, Jurewicz EC, Applegate LM, et al. Personality in essential tremor: further evidence of non-motor manifestations of the disease. J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):958-61. Abstract
12. Cohen O, Pullman S, Jurewicz E, et al. Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiologic characteristics. Arch Neurol. 2003 Mar;60(3):405-10. Abstract
13. Louis ED. Essential tremor. Lancet Neurol. 2005 Feb;4(2):100-10. Abstract
14. Shanker V. Essential tremor: diagnosis and management. BMJ. 2019 Aug 5;366:l4485.Full text Abstract
15. Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord. 2010 Apr 15;25(5):534-41. Abstract
16. Louis ED, Ottman R, Hauser WA. How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world. Mov Disord. 1998 Jan;13(1):5-10. Abstract
17. Haerer AF, Anderson DW, Schoenberg BS. Prevalence of essential tremor. Results from the Copiah County study. Arch Neurol. 1982 Dec;39(12):750-1. Abstract
18. Louis ED, Fried LP, Fitzpatrick AL, et al. Regional and racial differences in the prevalence of physician-diagnosed essential tremor in the United States. Mov Disord. 2003 Sep;18(9):1035-40. Abstract
19. Louis ED, Marder K, Cote L, et al. Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in northern Manhattan, NY. Arch Neurol. 1995 Dec;52(12):1201-5. Abstract
20. Rajput AH, Offord KP, Beard CM, et al. Essential tremor in Rochester, Minnesota: a 45-year study. J Neurol Neurosurg Psychiatry. 1984 May;47(5):466-70.Full text Abstract
21. Benito-Leon J, Bermejo-Pareja F, Morales JM, et al. Prevalence of essential tremor in three elderly populations of central Spain. Mov Disord. 2003 Apr;18(4):389-94. Abstract
22. Teravainen H, Larsen A, Fogelholm R. Comparison between the effects of pindolol and propranolol on essential tremor. Neurology. 1977 May;27(5):439-42. Abstract
23. Bain PG, Findley LJ, Thompson PD, et al. A study of hereditary essential tremor. Brain. 1994 Aug;117 (pt 4):805-24. Abstract
24. Findley LJ. Epidemiology and genetics of essential tremor. Neurology. 2000;54(11 Suppl 4):S8-S13. Abstract
25. Louis ED, Ottman R. How familial is familial tremor? The genetic epidemiology of essential tremor. Neurology. 1996 May;46(5):1200-5. Abstract
26. Stefansson H, Steinberg S, Petursson H, et al. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet. 2009 Mar;41(3):277-9.Full text Abstract
27. Thier S, Lorenz D, Nothnagel M, et al. Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor. Neurology. 2012 Jul 17;79(3):243-8.Full text Abstract
28. Müller SH, Girard SL, Hopfner F, et al. Genome-wide association study in essential tremor identifies three new loci. Brain. 2016 Dec;139(pt 12):3163-9.Full text Abstract
29. Louis ED, Ford B, Frucht S, et al. Risk of tremor and impairment from tremor in relatives of patients with essential tremor: a community-based family study. Ann Neurol. 2001 Jun;49(6):761-9. Abstract
30. Louis ED. Etiology of essential tremor: should we be searching for environmental causes? Mov Disord. 2001 Sep;16(5):822-9. Abstract
31. Louis ED, Factor-Litvak P, Liu X, et al. Elevated brain harmane (1-methyl-9H-pyrido[3,4-b]indole) in essential tremor cases vs. controls. Neurotoxicology. 2013 Sep;38:131-5.Full text Abstract
32. Louis ED, Benito-León J, Moreno-García S, et al. Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain. Neurotoxicology. 2013 Jan;34:264-8.Full text Abstract
33. Louis ED, Jiang W, Pellegrino KM, et al. Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor. Neurotoxicology. 2008 Mar;29(2):294-300.Full text Abstract
34. Dupuis MJ, Delwaide PJ, Boucquey D, et al. Homolateral disappearance of essential tremor after cerebellar stroke. Mov Disord. 1989;4(2):183-7. Abstract
35. Boecker H, Wills AJ, Ceballos-Baumann A, et al. The effect of ethanol on alcohol-responsive essential tremor: a positron emission tomography study. Ann Neurol. 1996 May;39(5):650-8. Abstract
36. Dubinski R, Hallett M. Glucose hypermetabolism of the inferior olive in patients with essential tremor. Ann Neurol. 1987;22:118.
37. Jenkins IH, Bain PG, Colebatch JG, et al. A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections. Ann Neurol. 1993 Jul;34(1):82-90. Abstract
38. Gallea C, Popa T, García-Lorenzo D, et al. Intrinsic signature of essential tremor in the cerebello-frontal network. Brain. 2015 Oct;138(pt 10):2920-33.Full text Abstract
39. Buijink AW, van der Stouwe AM, Broersma M, et al. Motor network disruption in essential tremor: a functional and effective connectivity study. Brain. 2015 Oct;138(pt 10):2934-47.Full text Abstract
40. Boelmans K, Kaufmann J, Bodammer N, et al. Involvement of motor pathways in corticobasal syndrome detected by diffusion tensor tractography. Mov Disord. 2009 Jan 30;24(2):168-75. Abstract
41. Elble RJ. Origins of tremor. Lancet. 2000 Apr 1;355(9210):1113-4. Abstract
42. Martin FC, Thu Le A, Handforth A. Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications. Mov Disord. 2005 Mar;20(3):298-305. Abstract
43. O'Hearn E, Molliver ME. Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline. Neuroscience. 1993 Jul;55(2):303-10. Abstract
44. Cheng MM, Tang G, Kuo SH. Harmaline-induced tremor in mice: videotape documentation and open questions about the model. Tremor Other Hyperkinet Mov (N Y). 2013 Dec 9;3:tre-03-205-4668-1.Full text Abstract
45. Lin CY, Louis ED, Faust PL, et al. Abnormal climbing fibre-Purkinje cell synaptic connections in the essential tremor cerebellum. Brain. 2014 Dec;137(pt 12):3149-59.Full text Abstract
46. Louis RJ, Lin CY, Faust PL, et al. Climbing fiber synaptic changes correlate with clinical features in essential tremor. Neurology. 2015 Jun 2;84(22):2284-6. Abstract
47. Kuo SH, Lin CY, Wang J, et al. Climbing fiber-Purkinje cell synaptic pathology in tremor and cerebellar degenerative diseases. Acta Neuropathol. Acta Neuropathol. 2017 Jan;133(1):121-38. Abstract
48. Louis ED, Kerridge CA, Chatterjee D, et al. Contextualizing the pathology in the essential tremor cerebellar cortex: a patholog-omics approach. Acta Neuropathol. 2019 Nov;138(5):859-76.Full text Abstract
49. Kuo SH, Lin CY, Wang J, et al. Deep brain stimulation and climbing fiber synaptic pathology in essential tremor. Ann Neurol. 2016 Sep;80(3):461-5. Abstract
50. Pan MK, Li YS, Wong SB, et al. Cerebellar oscillations driven by synaptic pruning deficits of cerebellar climbing fibers contribute to tremor pathophysiology. Sci Transl Med. 2020 Jan 15;12(526):eaay1769.Full text Abstract
51. Kuo SH, Tang G, Louis ED, et al. Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau. Acta Neuropathol. 2013 Jun;125(6):879-89.Full text Abstract
52. Lee M, Cheng MM, Lin CY, et al. Decreased EAAT2 protein expression in the essential tremor cerebellar cortex. Acta Neuropathol Commun. 2014 Nov 13;2:157.Full text Abstract
53. Babij R, Lee M, Cortés E, et al. Purkinje cell axonal anatomy: quantifying morphometric changes in essential tremor versus control brains. Brain. 2013 Oct;136(pt 10):3051-61.Full text Abstract
54. Louis ED, Lee M, Babij R, et al. Reduced Purkinje cell dendritic arborization and loss of dendritic spines in essential tremor. Brain. 2014 Dec;137(pt 12):3142-8.Full text Abstract
55. Kuo SH, Erickson-Davis C, Gillman A, et al. Increased number of heterotopic Purkinje cells in essential tremor. J Neurol Neurosurg Psychiatry. 2011 Sep;82(9):1038-40.Full text Abstract
56. Wang J, Kelly GC, Tate WJ, et al. Excitatory amino acid transporter expression in the essential tremor dentate nucleus and cerebellar cortex: a postmortem study. Parkinsonism Relat Disord. 2016 Nov;32:87-93. Abstract
57. Louis ED. A new twist for stopping the shakes? Revisiting GABAergic therapy for essential tremor. Arch Neurol. 1999 Jul;56(7):807-8. Abstract
58. Paris-Robidas S, Brochu E, Sintes M, et al. Defective dentate nucleus GABA receptors in essential tremor. Brain. 2012 Jan;135(Pt 1):105-16.Full text Abstract
59. Kralic JE, Criswell HE, Osterman JL, et al. Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice. J Clin Invest. 2005 Mar;115(3):774-9.Full text Abstract
60. Nietz A, Krook-Magnuson C, Gutierrez H, et al. Selective loss of the GABAAa1 subunit from Purkinje cells is sufficient to induce a tremor phenotype. J Neurophysiol. 2020 Oct 1;124(4):1183-97.Full text Abstract
61. Louis ED, Hernandez N, Dyke JP, et al. In vivo dentate nucleus gamma-aminobutyric acid concentration in essential tremor vs. controls. Cerebellum. 2018 Apr;17(2):165-72.Full text Abstract
62. Louis ED, Ford B, Barnes LF. Clinical subtypes of essential tremor. Arch Neurol. 2000 Aug;57(8):1194-8.Full text Abstract
63. Louis ED, Benito-León J, Ottman R, et al; Neurological Disorders in Central Spain (NEDICES) Study Group. A population-based study of mortality in essential tremor. Neurology. 2007 Nov 20;69(21):1982-9. Abstract
64. Deuschl G, Petersen I, Lorenz D, et al. Tremor in the elderly: essential and aging-related tremor. Mov Disord. 2015 Sep;30(10):1327-34.Full text Abstract
65. Bermejo-Pareja F, Louis ED, Benito-León J; Neurological Disorders in Central Spain (NEDICES) Study Group. Risk of incident dementia in essential tremor: a population-based study. Mov Disord. 2007 Aug 15;22(11):1573-80. Abstract
66. Muthuraman M, Deuschl G, Anwar AR, et al. Essential and aging-related tremor: differences of central control. Mov Disord. 2015 Oct;30(12):1673-80. Abstract
67. Kuo SH, Wang J, Tate WJ, et al. Cerebellar pathology in early onset and late onset essential tremor. Cerebellum. 2016 Apr;16(2):473-82. Abstract
68. Higgins JJ, Loveless JM, Jankovic J, et al. Evidence that a gene for essential tremor maps to chromosome 2p in four families. Mov Disord. 1998 Nov;13(6):972-7. Abstract
69. Tanner CM, Goldman SM, Lyons KE, et al. Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. Neurology. 2001 Oct 23;57(8):1389-91. Abstract
70. Kovach MJ, Ruiz J, Kimonis K, et al. Genetic heterogeneity in autosomal dominant essential tremor. Genet Med. 2001 May-Jun;3(3):197-9. Abstract
71. Deuschl G, Raethjen J, Lindemann M, et al. The pathophysiology of tremor. Muscle Nerve. 2001 Jun;24(6):716-35. Abstract
72. Thenganatt MA, Louis ED. Distinguishing essential tremor from Parkinson's disease: bedside tests and laboratory evaluations. Expert Rev Neurother. 2012 Jun;12(6):687-96.Full text Abstract
73. Kronenbuerger M, Konczak J, Ziegler W, et al. Balance and motor speech impairment in essential tremor. Cerebellum. 2009 Sep;8(3):389-98. Abstract
74. Palumbo B, Fravolini ML, Nuvoli S, et al. Comparison of two neural network classifiers in the differential diagnosis of essential tremor and Parkinson's disease by (123)I-FP-CIT brain SPECT. Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2146-53. Abstract
75. di Biase L, Brittain JS, Shah SA, et al. Tremor stability index: a new tool for differential diagnosis in tremor syndromes. Brain. 2017 Jul 1;140(7):1977-86.Full text Abstract
76. Sharifi S, Nederveen AJ, Booij J, et al. Neuroimaging essentials in essential tremor: a systematic review. Neuroimage Clin. 2014 May 9;5:217-31.Full text Abstract
77. Benito-Leon J, Louis ED. Clinical update: diagnosis and treatment of essential tremor. Lancet. 2007 Apr 7;369(9568):1152-4. Abstract
78. Benito-León J, Louis ED. Essential tremor: emerging views of a common disorder. Nat Clin Pract Neurol. 2006 Dec;2(12):666-78. Abstract
79. Trenado C, Amtage F, Huethe F, et al. Suppression of enhanced physiological tremor via stochastic noise: initial observations. PLoS One. 2014 Nov 14;9(11):e112782.Full text Abstract
80. Louis ED, Ottman R, Ford B, et al. The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology. 1997;16(3):124-33. Abstract
81. Zesiewicz TA, Elble RJ, Louis ED, et al. Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology. 2011 Nov 8;77(19):1752-5.Full text Abstract
82. Tolosa ES, Loewenson RB. Essential tremor: treatment with propranolol. Neurology. 1975 Nov;25(11):1041-4. Abstract
83. O'Suilleabhain P, Dewey RB, Jr. Randomized trial comparing primidone initiation schedules for treating essential tremor. Mov Disord. 2002 Mar;17(2):382-6. Abstract
84. Gorman WP, Cooper R, Pocock P, et al. A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis. J Neurol Neurosurg Psychiatry. 1986 Jan;49(1):64-8. Abstract
85. Gironell A, Kulisevsky J, Barbanoj M, et al. A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol. 1999 Apr;56(4):475-80. Abstract
86. Ondo W, Hunter C, Vuong KD, et al. Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. Mov Disord. 2000 Jul;15(4):678-82. Abstract
87. Pahwa R, Lyons K, Hubble JP, et al. Double-blind controlled trial of gabapentin in essential tremor. Mov Disord. 1998 May;13(3):465-7. Abstract
88. Huber SJ, Paulson GW. Efficacy of alprazolam for essential tremor. Neurology. 1988 Feb;38(2):241-3. Abstract
89. Ondo WG, Jankovic J, Connor GS, et al. Topiramate in essential tremor: a double-blind, placebo-controlled trial. Neurology. 2006 Mar 14;66(5):672-7. Abstract
90. Bruno E, Nicoletti A, Quattrocchi G, et al. Topiramate for essential tremor. Cochrane Database Syst Rev. 2017 Apr 14;4:CD009683.Full text Abstract
91. Flora ED, Perera CL, Cameron AL, et al. Deep brain stimulation for essential tremor: a systematic review. Mov Disord. 2010 Aug 15;25(11):1550-9. Abstract
92. Deuschl G, Bain P. Deep brain stimulation for tremor [correction of trauma]: patient selection and evaluation. Mov Disord. 2002;17 (Suppl 3):S102-11. Abstract
93. Okun MS, Fernandez HH, Pedraza O, et al. Development and initial validation of a screening tool for Parkinson disease surgical candidates. Neurology. 2004 Jul 13;63(1):161-3. Abstract
94. Okun MS, Fernandez HH, Rodriguez RL, et al. Identifying candidates for deep brain stimulation in Parkinson's disease: the role of the primary care physician. Geriatrics. 2007 May;62(5):18-24. Abstract
95. Okun MS, Rodriguez RL, Mikos A, et al. Deep brain stimulation and the role of the neuropsychologist. Clin Neuropsychol. 2007 Jan;21(1):162-89. Abstract
96. Rodriguez RL, Fernandez HH, Haq I, et al. Pearls in patient selection for deep brain stimulation. Neurologist. 2007 Sep;13(5):253-60. Abstract
97. Alesch F, Pinter MM, Helscher RJ, et al. Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor. Acta Neurochir (Wien). 1995;136(1-2):75-81. Abstract
98. Benabid AL, Pollak P, Gao D, et al. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg. 1996 Feb;84(2):203-14. Abstract
99. Benabid AL, Pollak P, Hommel M, et al. Treatment of Parkinson tremor by chronic stimulation of the ventral intermediate nucleus of the thalamus. Rev Neurol. (Paris) 1989;145(4):320-3. [In French.] Abstract
100. Blond S, Caparros-Lefebvre D, Parker F, et al. Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J Neurosurg. 1992 Jul;77(1):62-8. Abstract
101. Hubble JP, Busenbark KL, Wilkinson S, et al. Deep brain stimulation for essential tremor. Neurology. 1996 Apr;46(4):1150-3. Abstract
102. Koller W, Pahwa R, Busenbark K, et al. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol. 1997 Sep;42(3):292-9. Abstract
103. Krauss JK, Simpson RK, Jr, Ondo WG, et al. Concepts and methods in chronic thalamic stimulation for treatment of tremor: technique and application. Neurosurgery. 2001 Mar;48(3):535-41. Abstract
104. Lee JY, Kondziolka D. Thalamic deep brain stimulation for management of essential tremor. J Neurosurg. 2005 Sep;103(3):400-3. Abstract
105. Limousin P, Speelman JD, Gielen F, et al. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry. 1999 Mar;66(3):289-96. Abstract
106. Ondo W, Jankovic J, Schwartz K, et al. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor. Neurology. 1998 Oct;51(4):1063-9. Abstract
107. Pahwa R, Lyons KE, Wilkinson SB, et al. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg. 2006 Apr;104(4):506-12. Abstract
108. Schuurman PR, Bosch DA, Bossuyt PM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med. 2000 Feb 17;342(7):461-8. Abstract
109. Sydow O, Thobois S, Alesch F, et al. Multicentre European study of thalamic stimulation in essential tremor: a six year follow up. J Neurol Neurosurg Psychiatry. 2003 Oct;74(10):1387-91.Full text Abstract
110. Koller WC, Lyons KE, Wilkinson SB, et al. Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Mov Disord. 2001 May;16(3):464-8. Abstract
111. Koller WC, Lyons KE, Wilkinson SB, et al. Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor. Mov Disord. 1999 Sep;14(5):847-50. Abstract
112. Favilla CG, Ullman D, Wagle Shukla A, et al. Worsening essential tremor following deep brain stimulation: disease progression versus tolerance. Brain. 2012 May;135(Pt 5):1455-62. Abstract
113. Hariz MI, Shamsgovara P, Johansson F, et al. Tolerance and tremor rebound following long-term chronic thalamic stimulation for Parkinsonian and essential tremor. Stereotact Funct Neurosurg. 1999;72(2-4):208-18. Abstract
114. Hwynn N, Hass CJ, Zeilman P, et al. Steady or not following thalamic deep brain stimulation for essential tremor. J Neurol. 2011 Sep;258(9):1643-8. Abstract
115. Sixel-Doring F, Benecke R, Fogel W, et al; German Deep Brain Stimulation Association. Tiefe Hirnstimulation bei essenziellem Tremor. Empfehlungen der Deutschen Arbeitsgemeinschaft Tiefe Hirnstimulation. [Deep brain stimulation for essential tremor. Consensus recommendations of the German Deep Brain Stimulation Association]. Nervenarzt. 2009 Jun;80(6):662-5. [In German] Abstract
116. Fytagoridis A, Sandvik U, Aström M, et al. Long term follow-up of deep brain stimulation of the caudal zona incerta for essential tremor. J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):258-62. Abstract
117. Barbe MT, Liebhart L, Runge M, et al. Deep brain stimulation of the ventral intermediate nucleus in patients with essential tremor: stimulation below intercommissural line is more efficient but equally effective as stimulation above. Exp Neurol. 2011 Jul;230(1):131-7. Abstract
118. Chang WS, Chung JC, Kim JP, et al. Simultaneous thalamic and posterior subthalamic electrode insertion with single deep brain stimulation electrode for essential tremor. Neuromodulation. 2013 May-Jun;16(3):236-43. Abstract
119. Elias WJ, Lipsman N, Ondo WG, et al. A randomized trial of focused ultrasound thalamotomy for essential tremor. N Engl J Med. 2016 Aug 25;375(8):730-9.Full text Abstract
120. Mohammed N, Patra D, Nanda A. A meta-analysis of outcomes and complications of magnetic resonance-guided focused ultrasound in the treatment of essential tremor. Neurosurg Focus. 2018 Feb;44(2):E4. Abstract
121. Fukutome K, Kuga Y, Ohnishi H, et al. What factors impact the clinical outcome of magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor? J Neurosurg. 2020 May 1;134(5):1618-23.Full text Abstract
122. Meng Y, Solomon B, Boutet A, et al. Magnetic resonance-guided focused ultrasound thalamotomy for treatment of essential tremor: a 2-year outcome study. Mov Disord. 2018 Oct;33(10):1647-50. Abstract
123. Pouratian N, Baltuch G, Elias WJ, et al. American Society for Stereotactic and Functional Neurosurgery position statement on magnetic resonance-guided focused ultrasound for the management of essential tremor. Neurosurgery. 2020 Aug 1;87(2):E126-9.Full text Abstract
124. Niranjan A, Raju SS, Kooshkabadi A, et al. Stereotactic radiosurgery for essential tremor: retrospective analysis of a 19-year experience. Mov Disord. 2017 May;32(5):769-77. Abstract
125. O'Connor RJ, Kini MU. Non-pharmacological and non-surgical interventions for tremor: a systematic review. Parkinsonism Relat Disord. 2011 Aug;17(7):509-15. Abstract
126. Louis ED. Essential tremor. Clin Geriatr Med. 2006 Nov;22(4):843-57. Abstract
127. Findley LJ, Cleeves L, Calzetti S. Primidone in essential tremor of the hands and head: a double blind controlled clinical study. J Neurol Neurosurg Psychiatry. 1985 Sep;48(9):911-5. Abstract
128. Sasso E, Perucca E, Fava R, et al. Primidone in the long-term treatment of essential tremor: a prospective study with computerized quantitative analysis. Clin Neuropharmacol. 1990 Feb;13(1):67-76. Abstract
129. National Institute for Health and Care Excellence. Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor. Jun 2018 [internet publication].Full text
130. NHS England. Transcranial magnetic resonance guided focused ultrasound thalamotomy for treatment of medication-refractory essential tremor. Nov 2020 [internet publication].Full text
131. Jog M, Lee J, Scheschonka A, et al. Tolerability and efficacy of customized incobotulinumtoxinA injections for essential tremor: a randomized, double-blind, placebo-controlled study. Toxins (Basel). 2020 Dec 20;12(12):807.Full text Abstract
132. Auff E, Doppelbauer A, Fertl E. Essential tremor: functional disability vs. subjective impairment. J Neural Transm. 1991;33:105-10. Abstract
133. Koller WC, Busenbark K, Miner K. The relationship of essential tremor to other movement disorders: report on 678 patients. Essential Tremor Study Group. Ann Neurol. 1994 Jun;35(6):717-23. Abstract
Use of this content is subject to our disclaimer